Compugen (CGEN) Short Interest Ratio & Short Volume → He called Apple at $1.49 and now he says: “Buy these 6 AI stocks.” (From InvestorPlace) (Ad) Free CGEN Stock Alerts $1.97 -0.14 (-6.64%) (As of 09:34 AM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Compugen Short Interest DataCurrent Short Volume1,950,000 sharesPrevious Short Volume1,950,000 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$3.76 millionShort Interest Ratio / Days to Cover4.0Last Record DateApril 30, 2024Outstanding Shares86,620,000 sharesPercentage of Shares Shorted2.25%Today's Trading Volume96,721 sharesAverage Trading Volume552,076 sharesToday's Volume Vs. Average18% Short Selling Compugen ? Sign up to receive the latest short interest report for Compugen and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCGEN Short Interest Over TimeCGEN Days to Cover Over TimeCGEN Percentage of Float Shorted Over Time Ad Allegiance GoldDoes this make you sick?The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.Get your Free Wealth Protection Kit Compugen Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20241,950,000 shares $3.76 million No ChangeN/A4 $1.93 4/15/20241,950,000 shares $3.82 million -6.7%N/A3.4 $1.96 3/31/20242,090,000 shares $5.39 million +11.8%N/A3.2 $2.58 3/15/20241,870,000 shares $5.11 million +2.2%N/A2.1 $2.73 2/29/20241,830,000 shares $4.72 million -9.4%N/A0.7 $2.58 2/15/20242,020,000 shares $4.69 million +23.9%2.4%0.8 $2.32 Get the Latest News and Ratings for CGEN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Compugen and its competitors with MarketBeat's FREE daily newsletter. 1/31/20241,630,000 shares $3.93 million +1.9%2.0%0.6 $2.41 1/15/20241,600,000 shares $2.88 million -24.5%1.9%0.6 $1.80 12/31/20232,120,000 shares $4.20 million +45.2%2.5%0.9 $1.98 12/15/20231,460,000 shares $1.10 million -3.3%1.8%0.6 $0.76 11/30/20231,510,000 shares $1.00 million +11.9%1.8%8.3 $0.66 11/15/20231,350,000 shares $832,815.00 -10.6%1.6%7.7 $0.62 10/31/20231,510,000 shares $1.15 million No Change1.8%6.2 $0.76 10/15/20231,510,000 shares $1.27 million -4.4%1.8%5.9 $0.84 9/30/20231,580,000 shares $1.47 million -3.7%1.9%5.5 $0.93 9/15/20231,640,000 shares $1.75 million -6.3%2.0%5.5 $1.07 8/31/20231,750,000 shares $2.00 million +12.2%2.1%4.6 $1.14 8/15/20231,560,000 shares $1.62 million -3.1%1.9%2.9 $1.04 7/31/20231,610,000 shares $1.87 million +3.9%2.0%3.3 $1.16 7/15/20231,550,000 shares $1.94 million -3.1%N/A3.3 $1.25 6/30/20231,600,000 shares $1.82 million +4.6%N/A3.5 $1.14 6/15/20231,530,000 shares $2.10 million -9.5%N/A3.4 $1.37 5/31/20231,690,000 shares $1.72 million -7.1%2.1%4.2 $1.02 5/15/20231,820,000 shares $1.48 million +2.8%2.2%6.6 $0.81 4/30/20231,770,000 shares $1.04 million -7.8%2.2%6.5 $0.59 4/15/20231,920,000 shares $1.22 million +1.6%2.4%5.4 $0.63 3/31/20231,890,000 shares $1.33 million -5.5%2.3%4.4 $0.70 3/15/20232,000,000 shares $1.51 million -4.3%2.4%4 $0.76 2/28/20232,090,000 shares $1.65 million +14.2%2.6%3.6 $0.79 2/15/20231,830,000 shares $1.47 million -2.1%2.2%2.9 $0.81 1/31/20231,870,000 shares $1.62 million -7.4%2.3%2.8 $0.87 1/15/20232,020,000 shares $2.14 million +2.5%2.5%2.8 $1.06 12/30/20221,970,000 shares $1.41 million -24.2%2.4%2.3 $0.72 12/15/20222,600,000 shares $2.17 million -2.3%3.2%3 $0.84 11/30/20222,660,000 shares $3.19 million -0.4%3.3%2.7 $1.20 11/15/20222,670,000 shares $2.31 million -1.1%3.3%2.6 $0.87 10/31/20222,700,000 shares $2.57 million -4.6%3.3%2.1 $0.95 10/15/20222,830,000 shares $2.16 million +28.6%3.5%2.2 $0.76 9/30/20222,200,000 shares $1.45 million +3.8%2.7%1.9 $0.66 9/15/20222,120,000 shares $2.23 million -22.3%2.6%1.9 $1.05He called Apple at $1.49 and now he says: “Buy these 6 AI stocks.” (Ad)For over four decades, Louis Navellier has found the very best tech stocks... Before the rest of the market.Click for his six specific AI stock in the crosshairs CGEN Short Interest - Frequently Asked Questions What is Compugen's current short interest? Short interest is the volume of Compugen shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 1,950,000 shares of CGEN short. Learn More on Compugen's current short interest. What is a good short interest ratio for Compugen? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CGEN shares currently have a short interest ratio of 4.0. Learn More on Compugen's short interest ratio. Which institutional investors are shorting Compugen? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Compugen: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. How does Compugen's short interest compare to its competitors? Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Compugen: Genfit S.A. (0.18%), Adverum Biotechnologies, Inc. (8.04%), Cellectis S.A. (1.18%), Elevation Oncology, Inc. (11.46%), X4 Pharmaceuticals, Inc. (7.85%), Fennec Pharmaceuticals Inc (7.82%), Kodiak Sciences Inc. (3.76%), Cardiff Oncology, Inc. (9.88%), Century Therapeutics, Inc. (5.00%), INmune Bio, Inc. (13.54%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Compugen stock? Short selling CGEN is an investing strategy that aims to generate trading profit from Compugen as its price is falling. CGEN shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Compugen? A short squeeze for Compugen occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CGEN, which in turn drives the price of the stock up even further. How often is Compugen's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CGEN, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Genfit Short Interest Adverum Biotechnologies Short Interest Cellectis Short Interest Elevation Oncology Short Interest X4 Pharmaceuticals Short Interest Fennec Pharmaceuticals Short Interest Kodiak Sciences Short Interest Cardiff Oncology Short Interest Century Therapeutics Short Interest INmune Bio Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CGEN) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersDoes this make you sick?Allegiance GoldUrgent Nvidia WarningAltimetryThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarBill Gates is all about this tiny $2 stockTimothy SykesCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill Publishing